These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3109621)

  • 1. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.
    Bortnichak EA; Gordon AJ; Stevens EA
    Br Med J (Clin Res Ed); 1987 May; 294(6582):1289-90. PubMed ID: 3109621
    [No Abstract]   [Full Text] [Related]  

  • 2. Ulcerogenicity of piroxicam.
    Clinch D
    Br Med J (Clin Res Ed); 1987 Feb; 294(6569):439. PubMed ID: 3101913
    [No Abstract]   [Full Text] [Related]  

  • 3. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.
    Rossi AC; Hsu JP; Faich GA
    Br Med J (Clin Res Ed); 1987 Jan; 294(6565):147-50. PubMed ID: 3109543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.
    Armstrong CP; Blower AL
    Br Med J (Clin Res Ed); 1987 Mar; 294(6574):772. PubMed ID: 3105735
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal reaction to piroxicam.
    Spellman PG
    Vet Rec; 1992 Mar; 130(10):211. PubMed ID: 1509656
    [No Abstract]   [Full Text] [Related]  

  • 6. Piroxicam in recent epidemiologic studies.
    Bortnichak EA; Sachs RM
    Am J Med; 1986 Nov; 81(5B):44-8. PubMed ID: 3491542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions of piroxicam.
    Gerber D
    Drug Intell Clin Pharm; 1987 Sep; 21(9):707-10. PubMed ID: 2958264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptic ulcer and piroxicam.
    Inman WH; Rawson NS
    Br Med J (Clin Res Ed); 1985 Mar; 290(6472):932-3. PubMed ID: 3919846
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptic ulcers induced by piroxicam.
    Beermann B
    Br Med J (Clin Res Ed); 1985 Mar; 290(6470):789. PubMed ID: 3918758
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptic ulcers induced by piroxicam.
    Fok KH; George PJ; Vicary FR
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):117. PubMed ID: 3917708
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical benefits and comparative safety of piroxicam. Analysis of worldwide clinical trials data.
    Meisel AD
    Am J Med; 1986 Nov; 81(5B):15-21. PubMed ID: 3538866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Norwegian multicenter study.
    Husby G
    Am J Med; 1986 Nov; 81(5B):6-10. PubMed ID: 3538870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse effects following piroxicam (Felden)].
    Laake K; Kjeldaas L; Borchgrevink CF; Osnes M; Mosvold J
    Tidsskr Nor Laegeforen; 1983 Feb; 103(6):618-9. PubMed ID: 6868041
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapy.
    Rawson NS
    Ann Pharmacother; 1995; 29(7-8):676-80. PubMed ID: 8520079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Norway study: plasma concentrations, efficacy, and adverse events.
    Rugstad HE
    Am J Med; 1986 Nov; 81(5B):11-4. PubMed ID: 3538865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
    Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
    Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of solubility, dissolution release profile and reduction in ulcerogenicity of piroxicam by inclusion complex with skimmed milk.
    Sanka K; Munjulury VS; Mohd AB; Diwan PV
    Drug Deliv; 2014 Nov; 21(7):560-70. PubMed ID: 24266528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastroprotective effect of honey in Holtzman rats with piroxicam-induced gastric ulcer].
    Roldán-Rodríguez AE; Vega-Quispe EJ; Silva-Ocas I; Lemus-Arteaga KE; Gonzales-Saldaña JG; Ruiz-Urbina FN; Urtecho-Gaitan IF; Zamora-Mostacero VE; Vargas-Ferrer JE; Valverde-Quezada GJ; Vásquez-Sandoval KO; Huamán-Saavedra JJ
    Rev Gastroenterol Peru; 2016; 36(3):219-224. PubMed ID: 27716758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oesophageal lesions during treatment with piroxicam.
    Santucci L; Patoia L; Fiorucci S; Farroni F; Favero D; Morelli A
    BMJ; 1990 Apr; 300(6730):1018. PubMed ID: 2344500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.